
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1052 | 1070 | 1091 | 1154 | 1240 | 1881 |
Fund Return | 5.17% | 6.99% | 9.14% | 4.89% | 4.39% | 6.52% |
Place in category | 111 | 97 | 291 | 139 | 140 | 73 |
% in Category | 26 | 25 | 81 | 41 | 47 | 30 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Liontrust Special Situations Fund R | 26.07M | 1.87 | -1.97 | 6.72 | ||
Liontrust Special Situations Fund A | 3.35M | -0.17 | 2.28 | 6.77 | ||
Liontrust Special Situations Fund I | 1.43B | -4.92 | 0.39 | 6.44 | ||
Liontrust European Growth Fund A In | 8.22M | 8.50 | 11.23 | 11.98 | ||
Liontrust European Growth Fund I In | 709.18M | 4.37 | 8.39 | 11.50 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Artemis UK Select Fund I Acc | 1.86B | 0.90 | 12.67 | 9.00 | ||
Artemis UK Select Fund R Acc | 206.79M | 5.69 | 12.10 | 9.10 | ||
Artemis UK Select Fund I Inc GBP | 214.59M | 25.31 | 10.43 | 9.44 | ||
Artemis UK Select Fund G Inc GBP | 738.31M | 5.79 | 13.25 | - | ||
Fidelity Special Situations Fund W | 3.05B | 1.22 | 8.90 | 6.97 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 8.48 | 10,008.0 | -0.10% | |
Shell | GB00BP6MXD84 | 8.42 | 26.79 | -1.51% | |
Unilever | GB00B10RZP78 | 5.96 | 53.90 | +1.70% | |
BP | GB0007980591 | 5.13 | 331.70 | -2.90% | |
Relx | GB00B2B0DG97 | 4.09 | 3,737.00 | +0.11% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review